Larvol Delta - A-Study-of-Toripalimab-Injection-JS001--Cetuximab-in-Treatment-of-Advanced-Head-and-Neck-Squamous-Cell-Cancer

Erbitux (cetuximab) - Eli Lilly

Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Bioscience, Coherus Oncology

http://clinicaltrials.gov/ct2/show/NCT04856631

Aug 5, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next